Allogeneic hematopoietic cell transplantation (HCT) is used for patients with high-risk leukemias and bone marrow failure. In HCT, complete donor hematopoiesis is essential for sustained engraftment and prevention of relapse. In the post-transplant setting, clonal preleukemic precursors can re-emerge. In human AML, clonal preleukemic progression occurs in the hematopoietic stem cell [HSC] stage, and each heritable change increases the competitive competence of the clone vs normal HSC. We tested for mammalian germline stem cell competitions, for HSC competitions in aging, and in the progression of competitive HSC in human leukemias based on our early studies of stem cell competitions for germline and soma niches in the colonial chordate Botryllus schlosseri. B. schlosseri is an urochordate model organism that exhibits natural stem-cell mediated chimerism, and shares stem-cell associated gene sets and pathways with human and mouse. When two genetically distinct colonies meet, they either anastomose extracorporeal blood vessels to form a chimera with a common vasculature, or reject one another. In some chimeras, one of the chimeric partners undergoes partial or complete reabsorption. Circulating germ and/or somatic stem cells of one partner in a chimera can compete with and replace the germ line and/or soma of the other partner. Stem cell engraftment in B. schlosseri is regulated on four different levels: 1). fusion or rejection; 2). if fusion occurs, the body of the losing partner is resorbed; 3). competition between circulating somatic stem cells to seed buds for asexual whole body development; and 4). stem cell competition among germ line stem cells, which determines the genotype of the next generation. We discovered the gene (BHF) that controls fusion/rejection, and found that the other levels are also heritable. Thus, genetically distinct strains have somatic stem cells that, in a chimera, vary in their vulnerability to be resorbed, undergo competitions to win or lose differentiated tissue [akin to regeneration], and to win or lose germline niches. Each level of stem cell competition has biological and medical implications: resorption is a model for stem cell loss (failure to bud); somatic competitions relat to stem cell transplant engraftability, and germline stem cell competition determines which genotypes are inherited (fertility). To discover genes and key pathways that regulate stem cell functionality and engraftment potential, we established genetically distinct B. schlosseri strains with different levels of engraftment potential (the ability to not be resorbed in a chimera and/or o win in stem cell competition), sequenced their tissue specific RNAs, and analyzed their gene expression profiles. We arrived at a list of candidate genes and pathways that most likely alter stem cell competitive potential. We will use gene knockdown technology to assess the function of different genes in migrating stem cells in vivo that participate in organogenesis and gonad development. Eventually we will test whether these pathways regulate HSC competitions in allogeneic transplants.

Public Health Relevance

In bone marrow transplantation and similar therapies for leukemias and blood diseases, a major challenge is getting blood-forming stem cells from a donor to survive in a recipient. In this proposed work, we plan to study the mechanisms involved when stem cells from different individuals are combined (as in transplantation) and compete with one another. By identifying and enhancing traits that improve survival of donor cells in the recipient, this research is designed to improve transplant medicine.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM100315-07
Application #
9505917
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Somers, Scott D
Project Start
2012-05-15
Project End
2020-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
7
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Stanford University
Department
Pathology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Rosental, Benyamin; Kowarsky, Mark; Seita, Jun et al. (2018) Complex mammalian-like haematopoietic system found in a colonial chordate. Nature 564:425-429
Barkal, Amira A; Weiskopf, Kipp; Kao, Kevin S et al. (2018) Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy. Nat Immunol 19:76-84
Corey, Daniel M; Rosental, Benyamin; Kowarsky, Mark et al. (2016) Developmental cell death programs license cytotoxic cells to eliminate histocompatible partners. Proc Natl Acad Sci U S A 113:6520-5
Stolfi, Alberto; Sasakura, Yasunori; Chalopin, Domitille et al. (2015) Guidelines for the nomenclature of genetic elements in tunicate genomes. Genesis 53:1-14
Weissman, Irving L (2015) Stem cells are units of natural selection for tissue formation, for germline development, and in cancer development. Proc Natl Acad Sci U S A 112:8922-8
Weissman, Irving (2015) Evolution of normal and neoplastic tissue stem cells: progress after Robert Hooke. Philos Trans R Soc Lond B Biol Sci 370:20140364
Griggio, Francesca; Voskoboynik, Ayelet; Iannelli, Fabio et al. (2014) Ascidian mitogenomics: comparison of evolutionary rates in closely related taxa provides evidence of ongoing speciation events. Genome Biol Evol 6:591-605
Manni, Lucia; Gasparini, Fabio; Hotta, Kohji et al. (2014) Ontology for the asexual development and anatomy of the colonial chordate Botryllus schlosseri. PLoS One 9:e96434
Voskoboynik, Ayelet; Newman, Aaron M; Corey, Daniel M et al. (2013) Identification of a colonial chordate histocompatibility gene. Science 341:384-7
Rinkevich, Yuval; Voskoboynik, Ayelet; Rosner, Amalia et al. (2013) Repeated, long-term cycling of putative stem cells between niches in a basal chordate. Dev Cell 24:76-88

Showing the most recent 10 out of 11 publications